Fits and Starts: Trial Results from the CTAD Conference
Latest on investigational treatments in the pipeline. Two-part series on recent results published at the CTAD Conference from Pat McCaffrey for the Alz Forum.
Latest on investigational treatments in the pipeline. Two-part series on recent results published at the CTAD Conference from Pat McCaffrey for the Alz Forum.
Merck shook the field with news that people on verubecestat scored worse than those on placebo – find out more in this post from AlzForum
Developing computational algorithms & machine-learning techniques, to transform cross-sectional imaging data to a longitudinal picture and reconstruct the sequence of disease progression.
Many genetic variants predispose to Alzheimer’s disease, but exactly how remains a mystery.
The story of Carol Jennings and how her family’s uncommon form of Alzheimer’s led scientists to a breakthrough.
In AD, tau tangles correlate closely with neurodegeneration, but how they work their mischief remains unclear… or does it?
For everything there is a season—perhaps even cognition?
This week Lakshini talks to Anna Volkmer, Rosemary Townsend and Oliver Sawyer discussing of speech and language therapy and their research around communication training for people with language led dementia (primary progressive aphasia).
Blog from Dr Clarissa Giebel, discussing her work and the importance of dementia care research and helping people with dementia to remain independent for longer
Blog from Anna Volkmer, sharing exciting news on her work and publication on support for people with language led dementia
New study reveals that a drug that used to treat liver diseases could help to restore cells damaged by Alzheimer’s
Blog from Siobhan O’Connor exploring co-designing technology with people with dementia
Get all the support you need sent straight to your inbox. Research news, oppertunities, blogs, podcasts, jobs, events, funding calls and much more – every friday!